- Report
- September 2024
- 336 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- April 2024
- 137 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- April 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2024
- 122 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Clinical Trials
- July 2024
- 240 Pages
Global
From €2852EUR$3,000USD£2,396GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- March 2025
- 185 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- May 2024
- 129 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 136 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- May 2024
- 128 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Clinical Trials
- August 2024
- 240 Pages
Global
From €2852EUR$3,000USD£2,396GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- August 2024
- 150 Pages
Global
From €2651EUR$2,789USD£2,227GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- May 2024
- 100 Pages
Global
From €3755EUR$3,950USD£3,155GBP

The Age Related Macular Degeneration (AMD) Drug market is a subset of the Optical Disorders Drugs market. AMD is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. AMD is the leading cause of vision loss in people over the age of 50. Treatment options for AMD include drugs, laser therapy, and surgery.
Drugs used to treat AMD include anti-VEGF drugs, which block the growth of abnormal blood vessels in the eye, and corticosteroids, which reduce inflammation. These drugs are typically administered via intravitreal injections.
The AMD Drug market is highly competitive, with a number of companies offering treatments. These include Regeneron Pharmaceuticals, Novartis, Allergan, and Roche. Show Less Read more